Ascletis Pharma becomes first firm to file for IPO under new rules in Hong Kong
May 11, 2018
New regime allows biotech firms without profit or revenue to list
Ascletis Pharma has become the first biotechnology firm to file for an IPO in Hong Kong following recent reforms that allow biotech firms without profit or revenue to list.
The Hangzhou-based company submitted a highly redacted application for a listing published